Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates
Portfolio Pulse from
Precigen, Inc. (PGEN) reported a Q4 loss of $0.04 per share, which was better than the Zacks Consensus Estimate of a $0.06 loss. However, the company lagged in revenue estimates.
March 19, 2025 | 11:45 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Precigen, Inc. reported a Q4 loss of $0.04 per share, better than expected, but missed revenue estimates. This mixed result may lead to short-term stock price volatility.
Precigen's better-than-expected EPS loss of $0.04 compared to the $0.06 estimate is a positive sign, but missing revenue estimates could offset this. The mixed results may cause short-term volatility in the stock price as investors react to the earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100